Screener
Biodesix, Inc. BDSX Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Biodesix, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335036
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | $26,861 | $20,018 | $52,416 | $37,976 |
| Operating expenses: | ||||
| Direct costs and expenses | 4,820 | 4,031 | 9,025 | 7,734 |
| Research and development | 3,135 | 3,269 | 6,420 | 6,139 |
| Sales, marketing, general and administrative | 24,282 | 22,411 | 48,543 | 42,859 |
| Impairment loss on intangible assets | 12 | 26 | 17 | 99 |
| Total operating expenses | 32,249 | 29,737 | 64,005 | 56,831 |
| Loss from operations | (5,388) | (9,719) | (11,589) | (18,855) |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Biodesix, Inc.'s total revenue?
- Biodesix, Inc. (BDSX) reported total revenue of $26.86M in Q2 2026.
- How has Biodesix, Inc.'s total revenue changed year-over-year?
- Biodesix, Inc.'s total revenue increased by 34.2% year-over-year, from $20.02M to $26.86M.
- What is the long-term trend for Biodesix, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Biodesix, Inc.'s total revenue has grown at a 12.9% compound annual growth rate (CAGR), from $54.51M to $88.5M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Biodesix, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude